Sustained safety and efficacy of the magnesium scaffold: does the Magmaris scaffold call for the return of BRS research… and randomised controlled trials? - Suppr | 超能文献

Sustained safety and efficacy of the magnesium scaffold: does the Magmaris scaffold call for the return of BRS research… and randomised controlled trials?

作者信息

Onuma Yoshinobu, Serruys Patrick W

机构信息

National University of Ireland, Galway, Ireland.

出版信息

EuroIntervention. 2020 Feb 7;15(15):e1307-e1311. doi: 10.4244/EIJV15I15A238.

DOI:10.4244/EIJV15I15A238

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Sustained safety and efficacy of the magnesium scaffold: does the Magmaris scaffold call for the return of BRS research… and randomised controlled trials?

EuroIntervention. 2020 Feb 7;15(15):e1307-e1311. doi: 10.4244/EIJV15I15A238.

2

Early outcome of magnesium bioresorbable scaffold implantation in acute coronary syndrome-the initial report from the Magmaris-ACS registry.急性冠状动脉综合征中镁生物可吸收支架植入的早期结果- Magmaris-ACS 注册研究的初步报告。

Catheter Cardiovasc Interv. 2019 Apr 1;93(5):E287-E292. doi: 10.1002/ccd.28036. Epub 2018 Dec 10.

3

Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model.第二代镁支架 Magmaris：在猪冠状动脉模型中的器械设计和临床前评估。

EuroIntervention. 2017 Jul 20;13(4):440-449. doi: 10.4244/EIJ-D-16-00915.

4

The coronary resorbable magnesium scaffold Magmaris®: what we have learnt (so far…).冠状动脉可吸收镁支架 Magmaris®：我们迄今为止所学到的（内容）。

Minerva Cardiol Angiol. 2021 Apr;69(2):215-221. doi: 10.23736/S2724-5683.20.05184-1. Epub 2020 Apr 23.

5

Magmaris resorbable magnesium scaffold for the treatment of coronary heart disease: overview of its safety and efficacy.玛格瑞斯可吸收镁支架治疗冠心病：安全性和有效性概述。

Expert Rev Med Devices. 2019 Sep;16(9):757-769. doi: 10.1080/17434440.2019.1649133. Epub 2019 Jul 30.

6

Rather Thick, Yet Antithrombogenic: Is the Magmaris Scaffold a New Hope for Bioresorbable Coronary Scaffold?虽厚却具抗血栓形成能力：Magmaris支架会是生物可吸收冠状动脉支架的新希望吗？

Circ Cardiovasc Interv. 2017 Aug;10(8). doi: 10.1161/CIRCINTERVENTIONS.117.005663.

7

First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.通过灰阶血管内超声、虚拟组织学和光学相干断层扫描评估的第二代药物洗脱可吸收镁支架Magmaris在12个月时边缘血管反应的首次报告。一项Biosolve-II试验子研究。

Cardiovasc Revasc Med. 2019 May;20(5):392-398. doi: 10.1016/j.carrev.2019.02.019. Epub 2019 Feb 18.

8

MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.基于镁的生物可吸收支架与急性 ST 段抬高型心肌梗死患者血管舒缩功能：MAGSTEMI 试验：原理与设计。

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):64-70. doi: 10.1002/ccd.27825. Epub 2018 Sep 9.

9

Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study.药物洗脱可吸收镁支架植入术治疗ST段抬高型心肌梗死：一项试点研究。

J Invasive Cardiol. 2018 Jun;30(6):202-206. Epub 2018 Apr 15.

10

Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds: Magmaris Versus Absorb in a Porcine Arteriovenous Shunt Model.比较金属和聚合型可吸收生物支架的急性血栓形成：Magmaris 与 Absorb 在猪动静脉分流模型中的对比。

Circ Cardiovasc Interv. 2017 Aug;10(8). doi: 10.1161/CIRCINTERVENTIONS.116.004762.

引用本文的文献

1

Current situation and overview of resorbable magnesium scaffolds: a perspective for overcoming the remaining issues of polymeric bioresorbable scaffold.可吸收镁支架的现状与概述：克服聚合物生物可吸收支架遗留问题的展望

Cardiovasc Interv Ther. 2025 Apr;40(2):245-254. doi: 10.1007/s12928-024-01070-w. Epub 2024 Dec 21.

2

Bioresorbable Magnesium-Based Stent: Real-World Clinical Experience and Feasibility of Follow-Up by Coronary Computed Tomography: A New Window to Look at New Scaffolds.生物可吸收镁基支架：真实世界临床经验及冠状动脉计算机断层扫描随访的可行性：观察新型支架的新窗口

Biomedicines. 2023 Apr 11;11(4):1150. doi: 10.3390/biomedicines11041150.